Progyny (PGNY) Stock Falls on Q1 2026 Earnings

Progyny Inc. (PGNY) reported results for the first quarter of 2026 with revenue of $328.5 million, slightly below the consensus of $333.1 million. Diluted earnings per share came in at $0.29 versus an expected $0.30.

Revenue: $328.5 million (up 1.4% year‑over‑year).

Gross profit: $83.1 million (up 9.6% year‑over‑year).

Operating profit: $35.4 million (up 46.4% year‑over‑year).

Net income attributable to common shareholders: $24.2 million (up 60.9% year‑over‑year).

Diluted EPS: $0.29 (up 70.6% year‑over‑year).

Cash from operating activities: $45.9 million (down 7.8% year‑over‑year).

Capital expenditures (purchases of property, plant & equipment): $6.3 million (up 123.3% year‑over‑year).

Cash and cash equivalents: $131.6 million (up 20.5% year‑over‑year).

Cost of sales: $245.4 million (down 1.1% year‑over‑year).

Total liabilities: $259.0 million (down 1.6% year‑over‑year).

The company missed consensus on both top line and EPS — revenue was about 1.4% below estimates and EPS roughly 4.9% below estimates.

Despite the small miss, profitability metrics improved meaningfully, with sharp year‑over‑year gains in operating profit and net income.

Shares moved 10.0% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Progyny Inc. Insider Trading Activity

Progyny Inc. insiders have traded $PGNY stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:

PETER ANEVSKI (CHIEF EXECUTIVE OFFICER) purchased 79,500 shares for an estimated $1,930,896
MARK S. LIVINGSTON (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 21,975 shares for an estimated $560,362.
ALLISON SWARTZ (EVP, GC) has made 0 purchases and 6 sales selling 10,383 shares for an estimated $206,979.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

EARLY ACCESS

Receive PGNY Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Progyny Inc. Hedge Fund Activity

We have seen 147 institutional investors add shares of Progyny Inc. stock to their portfolio, and 172 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. removed 1,858,195 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $47,718,447
THRIVENT FINANCIAL FOR LUTHERANS removed 1,842,088 shares (-97.2%) from their portfolio in Q1 2026, for an estimated $31,278,654
WELLINGTON MANAGEMENT GROUP LLP added 1,621,688 shares (+260.9%) to their portfolio in Q4 2025, for an estimated $41,644,947
CITADEL ADVISORS LLC added 1,238,899 shares (+134.4%) to their portfolio in Q4 2025, for an estimated $31,814,926
MARSHALL WACE, LLP removed 1,072,733 shares (-92.5%) from their portfolio in Q4 2025, for an estimated $27,547,783
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ added 859,289 shares (+46.9%) to their portfolio in Q1 2026, for an estimated $14,590,727
ALLIANZ ASSET MANAGEMENT GMBH added 841,365 shares (+4141.8%) to their portfolio in Q4 2025, for an estimated $21,606,253

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

Progyny Inc. Analyst Ratings

Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citizens issued a "Market Outperform" rating on 01/20/2026

To track analyst ratings and price targets for Progyny Inc., check out Quiver Quantitative's $PGNY forecast page.

Progyny Inc. Price Targets

Multiple analysts have issued price targets for $PGNY recently. We have seen 7 analysts offer price targets for $PGNY in the last 6 months, with a median target of $28.0.

Here are some recent targets:

Glen Santangelo from Barclays set a target price of $23.0 on 03/20/2026
Richard Close from Canaccord Genuity set a target price of $19.0 on 03/11/2026
David Larsen from BTIG set a target price of $30.0 on 03/05/2026
Jailendra Singh from Truist Securities set a target price of $28.0 on 03/02/2026
Scott Schoenhaus from Keybanc set a target price of $28.0 on 03/02/2026
Constantine Davides from Citizens set a target price of $30.0 on 01/20/2026
Lisa Gill from JP Morgan set a target price of $26.0 on 11/11/2025